Skip to main content
Log in

Effect of omega-3 fatty acids on haemostatic functions in urocortin-treated obese rats

  • Original Paper
  • Published:
Journal of Physiology and Biochemistry Aims and scope Submit manuscript

Abstract

Urocortin 1 (UCN1) decreases food intake. We investigated the effects of UCN1 and omega-3 fatty acids (FA) on metabolic and coagulation parameters in high fat diet (HFD)-fed rats. Fifty male Sprague Dawley rats were divided into five groups; control, HFD, HFD with omega-3 FA, HFD with UCN1, and HFD with UCN1 and omega-3 FA. Food intake, body weight (BW), body mass index (BMI), Lee index, glucose, insulin, HOMA-IR, triglycerides, cholesterol, low (LDL) and high (HDL) density lipoproteins, fibrinogen, plasminogen activator inhibitor 1 (PAI-1), fibrin degradation product (FDP), clotting time, bleeding time, prothrombin time (PT), activated partial thromboplastin time (aPTT), and platelet aggregation were measured. Food intake, BW, BMI, Lee index, glucose, insulin, HOMA-IR, triglycerides, cholesterol, LDL, fibrinogen, platelet aggregation, PAI-1, and FDP increased while bleeding and clotting times, PT, and aPTT decreased in HFD rats. UCN1 decreased food intake, BW, BMI, Lee index, bleeding and clotting times, PT, and aPTT and increased fibrinogen, PAI-1, FDP, and platelet aggregation in HFD rats. Omega-3 FA decreased food intake, BW, BMI, Lee index, platelet aggregation, glucose, insulin, HOMA-IR, triglycerides, and increased HDL and bleeding time in HFD rats. We concluded that UCN1 worsens the hypercoagulable state in HFD rats while omega-3 FA improve the insulin resistance and decrease the platelet aggregation in those rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Afifi MM, Abbas AM (2011) Monosodium glutamate versus diet induced obesity in pregnant rats and their offspring. Acta Physiol Hung 98(2):177–188

    Article  PubMed  CAS  Google Scholar 

  2. Anfossi G, Russo I, Trovati M (2006) Platelet resistance to the anti-aggregating agents in the insulin resistant states. Curr Diabetes Rev 2:409–430

    Article  PubMed  CAS  Google Scholar 

  3. Asakawa A, Inui A, Ueno N, Makino S, Fujino MA, Kasuga M (1999) Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 116:1287–1292

    Article  PubMed  CAS  Google Scholar 

  4. Badimon L, Hernández Vera R, Vilahur G (2013) Atherothrombotic risk in obesity. Hamostaseologie 33:259–268

    Article  PubMed  CAS  Google Scholar 

  5. Basili S, Pacini G, Guagnano MT et al (2006) Insulin resistance as a determinant of platelet activation in obese women. J Am Coll Cardiol 48:2531–2538

    Article  PubMed  CAS  Google Scholar 

  6. Bessesen DH (2008) Update on obesity. J Clin Endocrinol Metab 93(6):2027–2034

    Article  PubMed  CAS  Google Scholar 

  7. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM, Elwood PC, Deadman NM (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction. Lancet 2:757–761

    Article  PubMed  CAS  Google Scholar 

  8. Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP (2008) Validation of simple indexes to assess insulin sensitivity during pregnancy in wistar and Sprague–Dawley rats. Am J Physiol Endocrinol Metab 295:E1269–E1276

    Article  PubMed  CAS  Google Scholar 

  9. Cade JE, Burley VJ, Greenwood DC, UK Women’s Cohort Study Steering Group (2004) The UK Women’s Cohort Study: Comparison of vegetarians, fish-eaters and meat-eaters. Public Health Nutr 7:871–878

    Article  PubMed  CAS  Google Scholar 

  10. Cohen MG, Rossi JS, Garbarino J, Bowling R, Motsinger-Reif AA, Sculer C, Dupont AG, Gabriel D (2011) Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: Beyond aspirin and clopidogrel. Thromb Res 128(4):335–40

    Article  PubMed  CAS  Google Scholar 

  11. Covington MB (2004) Omega-3 fatty acids. Am Fam Physician 70:133–40

    PubMed  Google Scholar 

  12. Cunnane SC, McAdoo KR, Horrobin DF (1986) n-3 essential fatty acids decrease weight gain in genetically obese mice. Br J Nutr 56:87–95

    Article  PubMed  CAS  Google Scholar 

  13. Darvall KAL, Sam RC, Silverman SH, Bradbury AW, Adam DJ (2007) Obesity and thrombosis. Eur J Vasc Endovasc Surg 33:223–33

    Article  PubMed  CAS  Google Scholar 

  14. Davi G, Guagnano MT, Ciabattoni G et al (2002) Platelet activation in obese women: Role of inflammation and oxidant stress. JAMA 288(16):2008–2014

    Article  PubMed  CAS  Google Scholar 

  15. De Pergola G, Pannacciulli N, Coviello M et al (2008) sP-selectin plasma levels in obesity: Association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis 18(3):227–232

    Article  PubMed  Google Scholar 

  16. Dieterich KD, Lehnert H, De Souza EB (1997) Corticotropin releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes 105:65–82

    Article  PubMed  CAS  Google Scholar 

  17. Diniz YS, Faine LA, Almeida JA, Silva MDP, Ribas BO, Novelli ELB (2002) Toxicity of dietary restriction of fat enriched diets on cardiac tissue. Food Chem Toxicol 40:1892–1899

    Article  Google Scholar 

  18. Fekete EM, Zorrilla EP (2007) Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: Ancient CRF paralogs. Front Neuroendocrinol 28:1–27

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  19. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, Franssen-van Hal N, Ruzickova J, Sponarova J, Drahota Z et al (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48:2365–75

    Article  PubMed  CAS  Google Scholar 

  20. Food and Drug Administration (FDA) (1997) Substances affirmed as generally recognized as safe: menhaden oil. Fed Reg 62:30751–7

    Google Scholar 

  21. Golub N, Geba D, Mousa SA, Williams G, Block RC (2011) Greasing the wheels of managing overweight and obesity with omega-3 fatty acids. Med Hypotheses 77:1114–1120

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Hainault I, Carolotti M, Hajduch E, Guichard C, Lavau M (1993) Fish oil in a high lard diet prevents obesity, hyperlipemia, and adipocyte insulin resistance in rats. Ann NY Acad Sci 683:98–101

    Article  PubMed  CAS  Google Scholar 

  23. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ (2008) Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives. Atherosclerosis 197:12–24

    Article  PubMed  CAS  Google Scholar 

  24. Hendra T, Betteridge DJ (1989) Platelet function, platelet prostanoids, and vascular prostacyclin in DM. Prostaglandins Leukot Essent Fatty Acids 35:197–212

    Article  PubMed  CAS  Google Scholar 

  25. Hill JO (2006) Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr Rev 27:750e61

    Google Scholar 

  26. Ivy AC, Nelson D, Bucher G (1940) Clotting time analysis. J Lab Clin Med 26:182

    Google Scholar 

  27. Kalupahana NS, Claycombe KJ, Moustaid-Moussa N (2011) (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: Mechanistic insights. Adv Nutr 2:304–316

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  28. Kalupahana NS, Claycombe KJ, Newman SJ, Stewart T, Siriwardhana N, Matthan N, Lichtenstein AH, Moustaid-Moussa N (2010) Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet induced obese mice via modulation of adipose tissue inflammation. J Nutr 140:1915–22

    Article  PubMed  CAS  Google Scholar 

  29. Kastin AJ, Pan W, Akerstrom V, Hackler L, Wang C, Kotz CM (2002) Novel peptide-peptide cooperation may transform feeding behavior. Peptides 23:2189–2196

    Article  PubMed  CAS  Google Scholar 

  30. Kelly T, Yang W, Chen CS et al (2008) Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 32:1431–1437

    Article  CAS  Google Scholar 

  31. Kinney JW, Scrmggs B, Avery DD (2000) Peripheral administration of urocortin suppresses operant responding for food reward. Peptides 22:583–587

    Article  Google Scholar 

  32. Kris-Etherton PM, Harris WS, Appel LJ (2003) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol 23:151–152

    Article  PubMed  CAS  Google Scholar 

  33. Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, Hensler M, Kazdova L, Ogston N, Baranowski M et al (2009) n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 52:941–51

    Article  PubMed  CAS  Google Scholar 

  34. Lemini C, Rubio-Póo C, Silva G, Garcia-Mondragon J, Zavala E, Mendoza-Patiño N, Castro D, Cruz-Almanza R, Mandoki JJ (1993) Anticoagulant and estrogenic effects of two new 17β-aminoestrogens, butolame [17β-(4-hydroxy-1-butylamino)-1, 3,5(10)-estratrien-3-ol] and pentolame [17β-(5-hydroxy-1-pentylamino)-1, 3,5(10)-estratrien-3-ol]. Steroids 58:457–461

    Article  PubMed  CAS  Google Scholar 

  35. Madsen L, Rustan AC, Vaagenes H, Berge K, Dyroy E, Berge RK (1999) Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference. Lipids 34:951–63

    Article  PubMed  CAS  Google Scholar 

  36. Matyšková R, Maletínská L, Maixnerová J, Pirník Z, Kiss A, Zelezná B (2008) Comparison of the obesity phenotypes related to monosodium glutamate effect on arcuate nucleus and/or the high fat diet feeding in C57Bl/6 and NMRI mice. Physiol Res 57:727–734

    PubMed  Google Scholar 

  37. Meganathan M, Gopal MK, Sasikala P, Mohan J, Gowdhaman N, Balamurugan K, Nirmala P, Santhakumari S, Samuel V (2011) Evaluation of hepatoprotective effect of omega 3-fatty acid against paracetamol induced liver injury in Albino Rats. Glob J Pharmacol 5(1):50–53

    Google Scholar 

  38. Mertens I, Van Gaal LF (2002) Obesity, haemostasis and the fibrinolytic system. Obes Rev 3:85–101

    Article  PubMed  CAS  Google Scholar 

  39. Meydan S, Altas M, Nacar A, Ozturk OH, Tas U, Zararsiz I, Sarsilmaz M (2012) The protective effects of omega-3 fatty acid against toluene-induced neurotoxicity in prefrontal cortex of rats. Hum Exp Toxicol 31(11):1179–85

    Article  PubMed  CAS  Google Scholar 

  40. Micallef M, Munro I, Phang M, Garg M (2009) Plasma n − 3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 102:1370–1374

    Article  PubMed  CAS  Google Scholar 

  41. Mustard JF, Hegard TB, RowSell HC (1964) Effects of adenosine nucleotides on platelet aggregation and clotting time. J Lab Clin Med 64:548

    PubMed  CAS  Google Scholar 

  42. Nascimento AF, Sugizaki MM, Leopoldo AS, Lima-Leopoldo AP, Nogueira CR, Novelli EL, Padovani CR, Cicogna AC (2008) Misclassification probability as obese or lean in hypercaloric and normocaloric diet. Biol Res 41(3):253–9

    Article  PubMed  Google Scholar 

  43. Nozu T, Martinez V, Rivier J, Tache Y (1999) Peripheral urocortin delays gastric emptying: Role of CRF receptor 2. Am J Physiol Gastrointest Liver Physiol 276:G867–G874

    CAS  Google Scholar 

  44. Oosthuizen W, Vorster HH, Jerling JC, Barnard HC, Smuts CM, Silvis N, Kruger A, Venter CS (1994) Both fish and olive oil lowered plasma fibrinogen in women with high baseline fibrinogen levels. Thromb Haemost 72:557–562

    PubMed  CAS  Google Scholar 

  45. Parrish CC, Pathy DA, Angel A (1990) Dietary fish oils limit adipose tissue hypertrophy in rats. Metabolism 39:217–219

    Article  PubMed  CAS  Google Scholar 

  46. Perrin MH, Sutton SW, Cervini LA, Rivier JE, Vale WW (1999) Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of CRF receptors. J Pharmacol Exp Ther 288:729–734

    PubMed  CAS  Google Scholar 

  47. Petkova-Kirova PS, Gagov HS, Duridanova DB (2000) Urocortin hyperpolarizes stomach smooth muscle via activation of Ca2+-sensitive K+ currents. J Muscle Res Cell Motil 21:639–645

    Article  PubMed  CAS  Google Scholar 

  48. Phang M, Lincz LF, Garg ML (2013) Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women. J Nutr 143:457–463

    Article  PubMed  CAS  Google Scholar 

  49. Phillips RJ, Powley TL (1996) Gastric volume rather than nutrient content inhibits food intake. Am J Physiol 271:R766–R769

    PubMed  CAS  Google Scholar 

  50. Puglisi MJ, Hasty AH, Saraswathi V (2011) The role of adipose tissue in mediating the beneficial effects of dietary fish oil. J Nutr Biochem 22:101–8

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  51. Reagan-Shaw S, Nihal M, Ahmad N (2007) Dose translation from animal to human studies revisited. FASEB J 22:659–661

    Article  PubMed  Google Scholar 

  52. Robinson JG, Stone NJ (2006) Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol 98:39––49i

    Article  Google Scholar 

  53. Rustan AC, Nossen JO, Christiansen EN, Drevon CA (1988) Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyl-transferase. J Lipid Res 29:1417–26

    PubMed  CAS  Google Scholar 

  54. Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M, Sasano H (2004) Urocortin 1 in colonic mucosa in patients with ulcerative colitis. J Clin Endocrinol Metab 89:5352–5361

    Article  PubMed  CAS  Google Scholar 

  55. Schenk S, Saberi M, Olefsky JM (2008) Insulin sensitivity: Modulation by nutrients and inflammation. J Clin Invest 118:2992–3002

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  56. Schwab JM, Chiang N, Arita M, Serhan CN (2007) Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869–74

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  57. Srinivasan M, Katewa SD, Palaniyappan A, Pandya JD, Patel MS (2006) Maternal high-fat diet consumption results in fetal malprogramming predisposing to the onset of metabolic syndrome-like phenotype in adulthood. Am J Physiol Endocrinol Metab 29:E792–E799

    Article  Google Scholar 

  58. Tanaka C, Asakawa A, Ushikai M et al (2009) Comparison of the anorexigenic activity of CRF family peptides. Biochem Biophys Res Commun 390:887–891

    Article  PubMed  CAS  Google Scholar 

  59. Targher G, Zoppini G, Moghetti P, Day CP (2010) Disorders of coagulation and hemostasis in abdominal obesity: Emerging role of fatty liver. Semin Thromb Hemost 36:41–48

    Article  PubMed  CAS  Google Scholar 

  60. Todoric J, Loffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhausl W, Stulnig TM (2006) Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsatu-rated fatty acids. Diabetologia 49:2109–19

    Article  PubMed  CAS  Google Scholar 

  61. Vanschoonbeek K, de Maat MP, Heemskerk JWM (2003) Fish oil consumption and reduction of arterial disease. J Nutr 133:657–660

    PubMed  CAS  Google Scholar 

  62. Vanschoonbeek K, Feijge MA, Paquay M, Rosing J, Saris W, Kluft C, Giesen PL, de Maat MP, Heemskerk JW (2004) Variable hypocoagulant effect of fish oil intake in humans: Modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 24(9):1734–40

    Article  PubMed  CAS  Google Scholar 

  63. Vasconcelos EM, Degasperi GR, de Oliveira HC, Vercesi AE, de Faria EC, Castilho LN (2009) Reactive oxygen species generation in peripheral blood monocytes and oxidized LDL are increased in hyperlipidemic patients. Clin Biochem 42:1222–7

    Article  PubMed  CAS  Google Scholar 

  64. Vaughan JM, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull A, Lovejoy D, Rivier C et al (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287–292

    Article  PubMed  CAS  Google Scholar 

  65. Von Diemen V, Trindade EN, Trindade MR (2006) Experimental model to induce obesity in rats. Acta Cir Bras 21(6):425–429

    Google Scholar 

  66. Wang L, Marti’nez V, Rivier JE, Tache’ Y (2001) Peripheral urocortin inhibits gastric emptying and food intake in mice: Differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol 281:R1401

    PubMed  CAS  Google Scholar 

  67. Xu Y, Zhang R, Chen J, Zhang Q, Wang J, Hu J, Guan X, Jin L, Fu H, Gui B, Guo Y, Li S (2009) Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors. Br J Pharmacol 157:1368–1379

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  68. Youssef MHM, Saleh NKM, Mohamed AA, El Khatib YA (2010) Enhanced platelet aggregation, hyperinsulinemia and low testosterone level in monosodium glutamate obese rats. Aust J Basic Appl Sci 4(10):4532–4539

    CAS  Google Scholar 

  69. Zorad S, Jezova D, Szabova L, Macho L, Tybitanclova K (2003) Low Number of insulin receptors but high receptor protein content in adipose tissue of rats with monosodium glutamate-induced obesity. Gen Physiol Biophys 22:557–560

    PubMed  CAS  Google Scholar 

Download references

Recommendation

Combination therapy of both UCN1 and omega-3 FA may be used as a possible therapy for obesity as both decrease food intake and omega-3 FA improve the hypercoagulable state which is worsened by UCN1. However, further investigations are needed to evaluate other parameters that may be modified by treating with UCN1 and omega-3 FA.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amr M. Abbas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Gendy, A.A., Abbas, A.M. Effect of omega-3 fatty acids on haemostatic functions in urocortin-treated obese rats. J Physiol Biochem 70, 809–820 (2014). https://doi.org/10.1007/s13105-014-0350-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13105-014-0350-3

Keywords

Navigation